Tag Archives: Abraxane

July, 2018

January, 2018

April, 2017

December, 2016

August, 2016

  • 5 August

    Momenta Halts Late-Stage Pancreatic Cancer Trial After Interim Analysis

    CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the Company has discontinued further accrual in its Phase 2 trial evaluating necuparanib in combination with Abraxane® and gemcitabine in patients with advanced …

January, 2016